Closed · RFA-AG-17-001 · CFDA 93.866 · Discretionary
Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $450K
- Award range
- Closed
- Status
- July 26, 2016
- Close date
- 3
- Expected awards
The verdict
Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01) is a closed discretionary listing from National Institutes of Health that offered Up to $450,000 across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $450K
- award range
- Closed
- application status
- 3
- expected awards
- 93.866
- CFDA program
Archived opportunity record
Limited Competition: Renewal of the Caenorhab… is closed (last close July 26, 2016). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed July 26, 2016
Est. Total Funding
$1,850,000
Expected Awards
3
Instrument
Cooperative Agreement
Description
The purpose of the Caenorhabditis Interventions Testing Program (CITP) is to test, under standardized conditions at a consortium of three sites, potential intervention strategies which may decelerate the rate of aging in genetically diverse species and strains of Caenorhabditis. All three laboratories in the CITP use identical standard operating procedures to test the same compounds (interventions) at the same concentrations and under the same conditions. The CITP will continue to use life span as its primary outcome for an intervention on a currently defined set of Caenorhabditis species and strains. This FOA calls for renewal and expansion of the scientific scope of the CITP with the following goals: 1. Continue to test compounds for effects on lifespan; 2. Increase the number of strains examined in lifespan studies as described in RFA AG-13-010. 3. Incorporate a limited set of studies for health span on selected compounds; 4. Incorporate studies to establish optimal effective doses when an initial test indicates the compound may be robust for its effect on lifespan across numerous strains of Caenorhabditis.
Wide-open applicant board · 15 Grants.gov doors
Limited Competition: Renewal of the Caenorhab… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the National Institutes of Health book (9,741 peers, 78% of 12,420).
- Code 00
- State governments
- Code 01
- County governments
- Code 02
- City or township governments
- Code 04
- Special district governments
- Code 05
- Independent school districts
- Code 06
- Public / state-controlled institutions of higher education
- Code 07
- Federally recognized tribal governments
- Code 08
- Public / Indian housing authorities
- Code 11
- Native American tribal organizations (other than Federally recognized tribal governments)
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 23
- Small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Limited Competition: Renewal of the Caenorhab… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.866 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |